Reaction Details |
| Report a problem with these data |
Target | D(2) dopamine receptor |
---|
Ligand | BDBM50302220 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_599588 (CHEMBL1040200) |
---|
Ki | 28±n/a nM |
---|
Citation | Rotella, DP; McFarlane, GR; Greenfield, A; Grosanu, C; Robichaud, AJ; Denny, RA; Feenstra, RW; Núñez-García, S; Reinders, JH; Neut, Mv; McCreary, A; Kruse, CG; Sullivan, K; Pruthi, F; Lai, M; Zhang, J; Kowal, DM; Carrick, T; Grauer, SM; Navarra, RL; Graf, R; Brennan, J; Marquis, KL; Pausch, MH Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia. Bioorg Med Chem Lett19:5552-5 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
D(2) dopamine receptor |
---|
Name: | D(2) dopamine receptor |
Synonyms: | D(2) dopamine receptor | DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2 | DRD2_HUMAN | Dopamine D2 receptor | Dopamine D2 receptor (D2) | Dopamine D2 receptor (D2R) | Dopamine D2A | Dopamine2-like | d2 |
Type: | Cell-surface receptors |
Mol. Mass.: | 50647.10 |
Organism: | Homo sapiens (Human) |
Description: | P14416 |
Residue: | 443 |
Sequence: | MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVS
REKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTA
SILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQN
ECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPL
KGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPP
SHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSR
RKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSA
VNPIIYTTFNIEFRKAFLKILHC
|
|
|
BDBM50302220 |
---|
n/a |
---|
Name | BDBM50302220 |
Synonyms: | 7-((1-((6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-3-yl)methyl)piperidin-4-yl)methoxy)benzo[d]oxazol-2(3H)-one | CHEMBL566396 |
Type | Small organic molecule |
Emp. Form. | C26H28FN3O3 |
Mol. Mass. | 449.5172 |
SMILES | Fc1ccc2[nH]c3CCC(CN4CCC(COc5cccc6[nH]c(=O)oc56)CC4)Cc3c2c1 |
Structure |
|